| scholarly article | Q13442814 |
| P2093 | author name string | Y Zhang | |
| K M Standifer | |||
| C D Simpson-Durand | |||
| P2860 | cites work | Pharmacological profiles of a novel opioid receptor-like1 (ORL(1)) receptor antagonist, JTC-801 | Q24673352 |
| Relations among posttraumatic stress disorder, comorbid major depression, and HPA function: A systematic review and meta-analysis | Q27004411 | ||
| Analyzing real-time PCR data by the comparative C(T) method | Q28131831 | ||
| Modification of Nociception and Morphine Tolerance by the Selective Opiate Receptor-Like Orphan Receptor Antagonist (–)-cis-1-Methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol (SB-612111) | Q28181106 | ||
| Differential effects of nociceptin/orphanin FQ (NOP) receptor agonists in acute versus chronic pain: studies with bifunctional NOP/μ receptor agonists in the sciatic nerve ligation chronic pain model in mice | Q28246174 | ||
| The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential | Q28289347 | ||
| A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat. | Q28344114 | ||
| Amygdala-dependent fear is regulated by Oprl1 in mice and humans with PTSD. | Q30437236 | ||
| Increased Nociceptive Sensitivity and Nociceptin/Orphanin FQ Levels in a Rat Model of PTSD | Q30459143 | ||
| Biomarkers in an animal model for revealing neural, hematologic, and behavioral correlates of PTSD. | Q30461101 | ||
| Social defeat stress produces prolonged alterations in acoustic startle and body weight gain in male Long Evans rats | Q30477881 | ||
| Involvement of the Nociceptin/Orphanin FQ-NOP receptor system in the ventrolateral periaqueductal gray following mechanical allodynia in chronic pain | Q48572481 | ||
| Stress-restress: effects on ACTH and fast feedback | Q48640591 | ||
| Nociceptin levels in the cerebrospinal fluid of chronic pain patients with or without intrathecal administration of morphine. | Q48660899 | ||
| Expression of ORL1 mRNA in some brain nuclei in neuropathic pain rats | Q48907799 | ||
| Role of amygdaloid nuclei in the anxiolytic-like effect of nociceptin/orphanin FQ in rats | Q50877013 | ||
| Anxiolytic-like effects of nociceptin/orphanin FQ in the elevated plus maze and in the conditioned defensive burying test in rats | Q50936615 | ||
| Effect of stress on hippocampal nociceptin expression in the rat. | Q50983647 | ||
| Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice | Q60504948 | ||
| Spinal analgesic activity of orphanin FQ/nociceptin and its fragments | Q73195158 | ||
| Agonist-stimulated [35S]GTPgammaS binding in brain modulation by endogenous adenosine | Q73436912 | ||
| Quantitative analysis of nociceptin in blood of patients with acute and chronic pain | Q78293372 | ||
| Cerebrospinal fluid biomarkers in experimental spinal nerve root injury | Q80980965 | ||
| The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors | Q30486707 | ||
| Effect of JTC-801 (nociceptin antagonist) on neuropathic pain in a rat model | Q31026718 | ||
| Nociceptin/orphanin FQ regulates neuroendocrine function of the limbic-hypothalamic-pituitary-adrenal axis | Q32065672 | ||
| In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist | Q33913544 | ||
| 4-Aminoquinolines: novel nociceptin antagonists with analgesic activity | Q33926915 | ||
| Animal research: reporting in vivo experiments: the ARRIVE guidelines | Q34116755 | ||
| Attenuation of neuropathic pain by the nociceptin/orphanin FQ antagonist JTC-801 is mediated by inhibition of nitric oxide production. | Q34192704 | ||
| A new synthetic approach of N-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl)benzamide (JTC-801) and its analogues and their pharmacological evaluation as nociceptin receptor (NOP) antagonists | Q34372291 | ||
| Anti-allodynic and anti-hyperalgesic effects of nociceptin receptor antagonist, JTC-801, in rats after spinal nerve injury and inflammation | Q34402257 | ||
| Understanding the co-occurrence of anxiety disorders and chronic pain: state-of-the-art | Q34998189 | ||
| Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex | Q35044849 | ||
| Veterans seeking treatment for posttraumatic stress disorder: what about comorbid chronic pain? | Q36841648 | ||
| Cortisol and post-traumatic stress disorder in adults: systematic review and meta-analysis | Q36989327 | ||
| Central nociceptin/orphanin FQ system elevates food consumption by both increasing energy intake and reducing aversive responsiveness | Q37175440 | ||
| The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence | Q37397573 | ||
| Single prolonged stress: toward an animal model of posttraumatic stress disorder | Q37634056 | ||
| Nociceptin/orphanin FQ and NOP receptor gene regulation after acute or repeated social defeat stress | Q37697775 | ||
| Synergistic anti-allodynic effects of nociceptin/orphanin FQ and cannabinoid systems in neuropathic mice. | Q39264518 | ||
| Guidelines for reporting experiments involving animals: the ARRIVE guidelines | Q39512979 | ||
| A cellular mechanism for the bidirectional pain-modulating actions of orphanin FQ/nociceptin | Q41739476 | ||
| Nociceptin/orphanin FQ content is decreased in forebrain neurones during acute stress | Q42435914 | ||
| Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: antagonism in brain and potentiation in spinal cord of the rat. | Q42561263 | ||
| Role of nociceptin/orphanin FQ and NOP receptors in the response to acute and repeated restraint stress in rats. | Q42745745 | ||
| An association between stress-induced disruption of the hypothalamic-pituitary-adrenal axis and disordered glucose metabolism in an animal model of post-traumatic stress disorder | Q43280675 | ||
| The putative OP(4) antagonist, [Nphe(1)]nociceptin(1-13)NH(2), prevents the effects of nociceptin in neuropathic rats | Q43651472 | ||
| Up-regulation of ORL-1 receptors in spinal tissue of allodynic rats after sciatic nerve injury. | Q44054567 | ||
| Orphanin FQ is a functional anti-opioid peptide. | Q44344202 | ||
| Analgesic effect of intrathecally administered nociceptin, an opioid receptor-like1 receptor agonist, in the rat formalin test | Q44346809 | ||
| Synthesis and pharmacological evaluation of bivalent antagonists of the nociceptin opioid receptor | Q44349521 | ||
| Nociceptin/orphanin FQ increases anxiety-related behavior and circulating levels of corticosterone during neophobic tests of anxiety. | Q44610338 | ||
| Prevalence of chronic pain, posttraumatic stress disorder, and persistent postconcussive symptoms in OIF/OEF veterans: polytrauma clinical triad | Q45296472 | ||
| The anxiolytic-like profile of the nociceptin receptor agonist, endo-8-[bis(2-chlorophenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octane-3-carboxamide (SCH 655842): comparison of efficacy and side effects across rodent species | Q46863626 | ||
| Roles of the bed nucleus of stria terminalis and of the amygdala in N/OFQ-mediated anxiety and HPA axis activation | Q46915999 | ||
| Further characterization of the prototypical nociceptin/orphanin FQ peptide receptor agonist Ro 64-6198 in rodent models of conflict anxiety and despair | Q48016277 | ||
| Levels of neuropeptides nocistatin, nociceptin/orphanin FQ and their precursor protein in a rat neuropathic pain model | Q48130236 | ||
| Anxiolytic-like effect of central administration of NOP receptor antagonist UFP-101 in rats submitted to the elevated T-maze. | Q48144501 | ||
| Elevated prepronociceptin, nociceptin/orphanin FQ and nocistatin concentrations in rat chronic constriction nerve injury and diabetic neuropathic pain models | Q48215205 | ||
| Differential regulation of hippocampal glucocorticoid receptors mRNA and fast feedback: relevance to post-traumatic stress disorder. | Q48300227 | ||
| Murine model of repeated exposures to conspecific trained aggressors simulates features of post-traumatic stress disorder | Q48431144 | ||
| Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes | Q48477441 | ||
| The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats | Q48493129 | ||
| Circuitry Underlying AntiOpioid Actions of Orphanin FQ in the Rostral Ventromedial Medulla | Q48548798 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | post-traumatic stress disorder | Q202387 |
| nociceptin | Q4327722 | ||
| P304 | page(s) | 571-582 | |
| P577 | publication date | 2014-07-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder | |
| P478 | volume | 172 |
| Q51067452 | Activation of the endogenous nociceptin system by selective nociceptin receptor agonist SCH 221510 produces antitransit and antinociceptive effect: a novel strategy for treatment of diarrhea-predominant IBS. |
| Q100381963 | Acute exposure of rats to a severe stressor alters the circadian pattern of corticosterone and sensitizes to a novel stressor: Relationship to pre-stress individual differences in resting corticosterone levels |
| Q89124044 | Affection of Comt1 genetype on anxiety and nociceptive sensitivity: an Ego-network analysis approach |
| Q91997345 | Animal models of PTSD: a challenge to be met |
| Q34518271 | Antidepressant-like Effects of Buprenorphine are Mediated by Kappa Opioid Receptors |
| Q89871011 | Blockade of NOP receptor modulates anxiety-related behaviors in mice exposed to inescapable stress |
| Q104509579 | Blockade of nociceptin/orphanin FQ signaling facilitates an active copying strategy due to acute and repeated stressful stimuli in mice |
| Q44350191 | Evaluation of cebranopadol, a dually acting nociceptin/orphanin FQ and opioid receptor agonist in mouse models of acute, tonic, and chemotherapy-induced neuropathic pain. |
| Q89948288 | Identification of significant gene biomarkers of low back pain caused by changes in the osmotic pressure of nucleus pulposus cells |
| Q49901474 | Imaging corticotropin-releasing-factor and nociceptin in addiction and PTSD models |
| Q92993446 | Methanol extract of semen Ziziphi Spinosae attenuates ethanol withdrawal anxiety by improving neuropeptide signaling in the central amygdala |
| Q92702908 | Modulation of the Negative Affective Dimension of Pain: Focus on Selected Neuropeptidergic System Contributions |
| Q37211503 | Nociceptin Opioid Receptor (NOP) as a Therapeutic Target: Progress in Translation from Preclinical Research to Clinical Utility |
| Q28257948 | Nociceptin and the nociceptin receptor in learning and memory |
| Q36744366 | Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems |
| Q42155707 | Parsing the hedonic and motivational influences of nociceptin on feeding using licking microstructure analysis in mice |
| Q57178745 | Psychosocial Stress Delays Recovery of Postoperative Pain Following Incisional Surgery in the Rat |
| Q35999761 | Quantitative Signaling and Structure-Activity Analyses Demonstrate Functional Selectivity at the Nociceptin/Orphanin FQ Opioid Receptor. |
| Q60916740 | Sex Differences in Nociceptin/Orphanin FQ Peptide Receptor-Mediated Pain and Anxiety Symptoms in a Preclinical Model of Post-traumatic Stress Disorder |
Search more.